Keyphrases
Interferon-α (IFN-α)
100%
Human Cells
100%
Pseudomonas Aeruginosa (P. aeruginosa)
100%
Mouse Cells
100%
Combined Treatment
100%
Pseudomonas
88%
Protein Synthesis
44%
Virus Release
33%
Enhancement Phenomenon
33%
Virus
22%
NIH3T3
22%
Dose Effect
11%
Biological Activity
11%
Biological Effects
11%
Nicotinamide Adenine Dinucleotide (NAD+)
11%
Sarcoma
11%
Retrovirus
11%
Mammalian Cells
11%
Two-cell
11%
Cell Surface Receptor
11%
Direct Interaction
11%
Cellular Proteins
11%
3T3 Mouse Fibroblast
11%
Amniotic Cells
11%
Toxin Concentration
11%
Combined Biological Effect
11%
Human Amnion
11%
Elongation Factor 2
11%
Immunology and Microbiology
Interferon Type I
100%
Human Cell
100%
Mouse
100%
Pseudomonas aeruginosa
100%
Pseudomonas
88%
Protein Synthesis
44%
Biological Activity
33%
Virus Release
33%
Cell Line
22%
Fibroblast
11%
Amnion Cell
11%
Moloney Murine Sarcoma Virus
11%
Elongation Factor 2
11%
Retrovirus
11%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Pseudomonas aeruginosa
100%
Interferon
100%
Pseudomonas
88%
Biological Activity
11%
Retrovirus
11%
Cell Protein
11%
Adenine
11%
Cell Receptor
11%
Nicotinamide Adenine Dinucleotide
11%
Moloney Murine Sarcoma Virus
11%
Elongation Factor 2
11%